Necdet SÜT, İlker YILMAM, Osman Nuri HATİPOĞLU, Ebru EDİS ÇAKIR

Economic burden of nosocomial pneumonia in non-intensive care clinics

Giriş : Literatürdeki hastanede gelişen pnömoniler (HGP) ile ilişkilimaliyet verilerinin hemen hepsi ventilatörle ilişkili pnömonili hasta-larla yapılan çalışmalardan elde edilmiştir. Bu çalışmada amaçhastane kliniklerinde yatan hastalarda pnömoni gelişmesinin maliyükünü saptamaktır. Materyal ve Metod: Yo ğun bakım dışı kliniklerde pnömoni gelişen ya ş ortalamas ı 64.53 ± 14.92 olan 97si erkek toplam 154 HGPlierişkin hastaya ait maliyet verileri prospektif olarak kaydedildi. Karşıla ştırma için ayn ı tarihler aras ında ayn ı tan ılar ile hastanede yatan,ya şı (ort: 65.66 ± 13.86) ve cinsiyeti (94ü erkek) benzer olup (p> 0.05) hastanede yattığı süre içinde pnömoni gelişmemiş olan 148olgu da kontrol grubuna alındı. Her iki gruptaki hastaların hastanede yattıkları gün sayıları ve hastane otomasyon program ından(Avicenna) elde edilen maliyet verileri Mann-Whitney U testiyle karşıla ştırıldı.Bulgular: HGPli hastalarda ortalama yatış gün say ısı 32.8 iken kontrol grubunda 9.8 idi (p< 0.0001). Yatak maliyeti HGPli hastagrubunda ortalama 631$ iken kontrol grubunda 153$ olarak hesaplandı (p< 0.0001). Toplam maliyet HGPli grupta ortalama 6241$iken kontrol grubunda 1117$ olarak tespit edildi (p< 0.0001).Sonuç: HGP, yatış süresini yakla şık 3.5, yatak maliyetini 4, toplam maliyeti 5.5 kat artıran mali yükü yüksek bir hastalıktır.

Yoğun bakımdışı kliniklerde gelişen Hastanede geliş en pnömoninin mali yükü

Introduction: Almost all data on the cost of nosocomial pneumonia (NP) in the literature is associated with ventilator-associatedpneumonia. This study aims to determine the economic burden of nosocomial pneumonia in clinical inpatients.Materials and Methods: Data on costs of the 154 adult patients (97 male, 57 female; mean age 64.53 ± 14.92) who were hospital-ized in non-intensive care clinics and developed NP were recorded prospectively. The control group consisted of 148 patientswithout pneumonia matched for age (mean age 65.66 ± 13.86), sex (94 male), diagnosis, and hospitalization date. Data obtainedfrom both groups of patients for the number of hospitalization days and the data obtained from the hospital automation program(Avicenna) for costs were compared using the Mann-Whitney U test.Results: While the mean duration of hospitalization was 32.8 days in patients with NP, it was 9.8 (p< 0.0001) in the control group.The cost of hospital beds was $631 for NP patients and $153 for the controls (p< 0.0001). The total cost was $6241 for NP patientsand $1117 for the controls (p< 0.0001).Conclusion: NP is a high-cost condition that increases the duration of hospitalization 3.5-fold, hospital-bed cost 4-fold, and the totalcost 5-fold.

PDF

___

1. American Thoracic Society Documents. Guidelines for the Management of Adults with Hospital-acquired, Ventilator- associated and Healthcare-associated Pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
2. Craven DE, Steger KA. Epidemiology of nosocomial pneu- monia: new perspectives on an old disease. Chest 1995;108:1-16.
3. Dietrich ES, Demmler M, Schulgen G, Fekec K, Mast O, Pelz K, et al. Nosocomial pneumonia: A cost of illness analysis. Infection 2002;30:61-7.
4. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator- associated pneumo- nia: a systematic review. Crit Care Med 2005;33:2184-93.
5. Erbay RH, Yalcin AN, Zincir M, Serin S, Atalay H. Costs and risk factors for ventilator-associated pneumonia in a Turkısh university hospitals intensive care unit: a case- control study. BMC Pulm Med 2004;4:3.
6. Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, et al. Epidemiology and outcomes of ventilator- associated pneumonia in a large US database. Chest 2002;122:2115-21.
7. Rosenthal VD, Guzman S, Migone O, Safdar N. The attrib- utable cost and length of hospital stay because of nosoco- mial pneumonia in intensive care units in 3 hospitals in Argentina: A prospective, matched analysis. Am J Infect Control 2005;33:157-61.
8. Eagy KJ, Nicolau DP, Kuti JL. Impact of superinfection on hospital length of stay and costs in patients with ventilator- associated pneumonia. Semin Respir Crit Care Med 2009;30:116-23.
9. Kappstein I, Schulgen G, Beyer U, Gieger K, Schumacher M, Daschner FD. Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit. Eur J Clin Microbiol Infect Dis 1992;11:504-8.
10. Cocanour CS, Ostrosky-Zeichner L, Peninger M, Garbade D, Tidemann T, Domonoske BD, et al. Cost of ventilator- associated pneumonia in a shock trauma intensive care unit. Surg Infect 2005;6:65-7.
11. Thompson DA, Makary MA, Dorman T, Pronovost PJ. Clinical and economic outcomes of hospital acquired pneumonia in intra-abdominal surgery patients. Ann Surg 2006;243:547-52.
12. Penel N, Lefebvre JL, Cazin JL, Clisant S, Neu JC, Dervaux B et al. Additional direct medical costs associated with nosocomial infections after head and neck cancer surgery: a hospital- perspective analysis. Int J Oral Maxillofac Surg 2008;37:135-9.
13. Herer B, Fuhrman C, Gazevic Z, Cabrit R, Chouiad C. Management of nosocomial pneumonia on a medical ward: a comparative study of outcomes and costs of inva- sive procedures. Clin Microbiol Infect 2009;15:165-72.
14. Cakir Edis E, Hatipoglu ON, Yilmam I, Eker A, Tansel O, Sut N. Hospital- acquired pneumonia developed in non- intensive care units. Respiration 2009;78:416-22.
15. Turkish Thoracic Society Documents. Guidelines for the Management of Adults with Hospital-acquired Pneumonia 2002. Turkish Thoracic Journal 2002;3:1-13.
16. www.tcmb.gov.tr
17. Ewig S, Bauer T, Torres A. The pulmonary physician in critical care: Nosocomial pneumonia. Thorax 2002;57:366- 71.
18. Boyce JM, Potter- Bynoe G, Dziobek L, Solomon SL. Nosocomial pneumonia in Medicare patients. Hospital costs and reimbursement patterns under the prospective payment system. Arch Intern Med 1991;151:1109-14.